Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)
Koralo GmbH · NCT07407777
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- January 19, 2026
- Record last updated
- February 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of the study is to evaluate the gut-related well-being and mood effects of a food ingredient obtained from the co-fermentation of oyster mushroom mycelium (Pleurotus pulmonarius), microalgae (Chlorella vulgaris), and bamboo fibre in healthy adults (aged 18+) experiencing minor gastrointestinal discomfort during an intervention period of 30 days. The participants will be allocated into two unbalanced groups to determine relationships between the measurable outcomes and the dose levels at three different time points: start of the study (baseline), 15 days (middle), and 30 days (end-point), during which participants will be asked to complete GSRS and POMS-2-SF questionnaire
Being studied: Food ingredient of oyster mushroom mycelium (Pleurotus pulmonarius) and microalgae (Chlorella vulgaris)
Conditions: Gastrointestinal Discomfort; Digestive Well Being; Gut-related Symptoms
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Adults aged 18 years or older
Generally healthy individuals
Experience minor, non-clinical gastrointestinal discomfort at least twice per week for ≥3 months
Willing to consume the study product once daily for 30 days
Able to dissolve and consume the powdered product in a beverage
Able to read, understand, and complete electronic questionnaires in English
Access to a smartphone or computer for study participation
Provide electronic informed consent
Exclusion Criteria
- Diagnosed gastrointestinal disease (e.g., IBS, IBD, GERD requiring medication)
Use of medications affecting gastrointestinal function or mood within the past 30 days
Initiation of new gut-, immune-, or mood-related supplements within 15 days prior to study start
Known allergy or sensitivity to study product components
Pregnancy or breastfeeding
Major chronic medical condition that could interfere with study participation or data interpretation
Participation in another interventional clinical study within the past 30 days
Inability or unwillingness to comply with study procedures
Recruiting US locations
Alethios, Inc.
San Francisco, CA 94109
Site contact: Zoe Benham, B.S. · 9562771765 · zoe@alethios.com
Study contacts (from the official record)
- Guido Albanese, PhD · +49 163 9144333 · guido@koralo-foods.com
- Zoe Benham, B.S. · zoe@alethios.com
Similar studies in California
All nutrition & metabolism studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1/Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals
- Location
- Los Angeles, CA + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
The Effects of Dietary Supplementation on Serum Protein Glycosylation
University of California, Davis
- Location
- Sacramento, CA
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteersPhase 1
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
University of California, San Diego
- Location
- San Diego, CA
- Eligibility basics
- Ages 60+